Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!

Berzenji L, Beckers P, Van Schil PE.

J Thorac Dis. 2019 May;11(Suppl 9):S1153-S1156. doi: 10.21037/jtd.2019.04.36. No abstract available.

2.

Surgery or stereotactic body radiotherapy for early-stage lung cancer: two sides of the same coin?

Berzenji L, Van Schil PE.

Eur Respir J. 2019 Jun 20;53(6). pii: 1900711. doi: 10.1183/13993003.00711-2019. Print 2019 Jun. No abstract available.

PMID:
31221681
3.

Diagnostic and clinical features of lung cancer associated with cystic airspaces.

Snoeckx A, Reyntiens P, Carp L, Spinhoven MJ, El Addouli H, Van Hoyweghen A, Nicolay S, Van Schil PE, Pauwels P, van Meerbeeck JP, Parizel PM.

J Thorac Dis. 2019 Mar;11(3):987-1004. doi: 10.21037/jtd.2019.02.91. Review.

4.

Multicenter Phase II Clinical Trial of Isolated Lung Perfusion in Patients With Lung Metastases.

Beckers PAJ, Versteegh MIM, Van Brakel TJ, Braun J, Van Putte B, Maat APWM, Vergauwen W, Rodrigus I, Den Hengst W, Lardon F, De Bruijn E, Guetens G, De Boeck G, Gielis JF, Lauwers P, Denissen L, Hendriks JMH, Van Schil PE.

Ann Thorac Surg. 2019 Jul;108(1):167-174. doi: 10.1016/j.athoracsur.2019.02.071. Epub 2019 Apr 2.

PMID:
30951699
5.

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S.

Ann Oncol. 2019 May 1;30(5):863-870. doi: 10.1093/annonc/mdy474. No abstract available.

PMID:
30715168
6.

Intrapericardial cavernous hemangioma: an unusual mediastinal tumor!

Cogen A, Haine SE, Paelinck BP, Van Herck PL, Pauwels P, Van Schil PE.

Acta Cardiol. 2019 Jan 16:1-2. doi: 10.1080/00015385.2018.1554736. [Epub ahead of print] No abstract available.

PMID:
30650037
7.

Commentary: Size and margin do matter, but is it the whole story?

Beckers PAJ, Berzenji L, Van Schil PE.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):1658-1659. doi: 10.1016/j.jtcvs.2018.11.036. Epub 2018 Nov 23. No abstract available.

PMID:
30554794
8.

A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205).

Raskin J, Surmont V, Cornelissen R, Baas P, van Schil PEY, van Meerbeeck JP.

Transl Lung Cancer Res. 2018 Oct;7(5):593-598. doi: 10.21037/tlcr.2018.05.07. Review.

9.

Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations.

De Bondt C, Psallidas I, Van Schil PEY, van Meerbeeck JP.

Transl Lung Cancer Res. 2018 Oct;7(5):562-573. doi: 10.21037/tlcr.2018.10.02. Review.

10.

Extrapleural pneumonectomy: still indicated?

Domen A, Berzenji L, Hendriks JMH, Yogeswaran SK, Lauwers P, Van Meerbeeck JP, Van Schil PE.

Transl Lung Cancer Res. 2018 Oct;7(5):550-555. doi: 10.21037/tlcr.2018.07.07. Review.

11.

The eighth TNM classification for malignant pleural mesothelioma.

Berzenji L, Van Schil PE, Carp L.

Transl Lung Cancer Res. 2018 Oct;7(5):543-549. doi: 10.21037/tlcr.2018.07.05. Review.

12.

Non-small cell lung cancer transgressing an adjacent fissure: does one T category fit all?

Van Schil PE.

J Thorac Dis. 2018 Sep;10(Suppl 26):S3290-S3291. doi: 10.21037/jtd.2018.08.106. No abstract available.

13.

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv192-iv237. doi: 10.1093/annonc/mdy275. No abstract available.

14.

MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): study protocol of a multicenter randomised controlled trial.

Bousema JE, Dijkgraaf MGW, Papen-Botterhuis NE, Schreurs HW, Maessen JG, van der Heijden EH, Steup WH, Braun J, Noyez VJJM, Hoeijmakers F, Beck N, van Dorp M, Claessens NJM, Hiddinga BI, Daniels JMA, Heineman DJ, Zandbergen HR, Verhagen AFTM, van Schil PE, Annema JT, van den Broek FJC; MEDIASTrial study group.

BMC Surg. 2018 May 18;18(1):27. doi: 10.1186/s12893-018-0359-6.

15.

Myasthenia gravis appearing after thymectomy heralding recurrent thymoma.

Beckers PAJ, Mercelis R, Heyman S, Verheuen L, Lauwers P, Hendriks JM, Van Schil PE.

Acta Chir Belg. 2019 Jun;119(3):195-197. doi: 10.1080/00015458.2018.1438556. Epub 2018 May 17.

PMID:
29768973
16.

The 8th TNM edition for lung cancer: a critical analysis.

Van Schil PE, Rami-Porta R, Asamura H.

Ann Transl Med. 2018 Mar;6(5):87. doi: 10.21037/atm.2017.06.45. Review.

17.

Mesothelioma With a Large Prevascular Lymph Node: N1 Involvement or Something Different?

Berzenji L, Van Schil PE, Snoeckx A, Hertoghs M, Carp L.

Ann Thorac Surg. 2018 May;105(5):e189-e191. doi: 10.1016/j.athoracsur.2017.12.016.

PMID:
29355487
18.

Surgery compared to stereotactic body radiation therapy for early-stage non-small cell lung cancer: better, equivalent or worse?

Van Schil PE.

J Thorac Dis. 2017 Nov;9(11):4230-4232. doi: 10.21037/jtd.2017.10.36. No abstract available.

19.

Wolf in Sheep's Clothing: Primary Lung Cancer Mimicking Benign Entities.

Snoeckx A, Dendooven A, Carp L, Desbuquoit D, Spinhoven MJ, Lauwers P, Van Schil PE, van Meerbeeck JP, Parizel PM.

Lung Cancer. 2017 Oct;112:109-117. doi: 10.1016/j.lungcan.2017.07.037. Epub 2017 Aug 5. Review.

PMID:
29191583
20.

Introducing TOPMAST, the first double-blind randomized clinical trial specifically dedicated to perioperative maintenance fluid therapy in adults.

Hendrickx S, Van Vlimmeren K, Baar I, Verbrugghe W, Dams K, Van Cromphaut S, Roelant E, Embrecht B, Wittock A, Mertens P, Hendriks JM, Lauwers P, Van Schil PE, Van Craenenbroeck AH, Van den Wyngaert T, Jorens P, Van Regenmortel N.

Anaesthesiol Intensive Ther. 2017;49(5):366-372. doi: 10.5603/AIT.a2017.0070. Epub 2017 Nov 24.

21.

Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology.

Snoeckx A, Reyntiens P, Desbuquoit D, Spinhoven MJ, Van Schil PE, van Meerbeeck JP, Parizel PM.

Insights Imaging. 2018 Feb;9(1):73-86. doi: 10.1007/s13244-017-0581-2. Epub 2017 Nov 15. Review.

22.

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer.

Van Schil PE, Berzenji L, Yogeswaran SK, Hendriks JM, Lauwers P.

Front Oncol. 2017 Oct 26;7:249. doi: 10.3389/fonc.2017.00249. eCollection 2017. Review.

23.

Oligometastatic non-small cell lung cancer: is there a role for locoregional therapy?

Berzenji L, Van Schil PE.

J Thorac Dis. 2017 Jul;9(7):1814-1817. doi: 10.21037/jtd.2017.06.108. No abstract available.

24.

Optimal Treatment of Stage IIIA-N2 Non-Small Cell Lung Cancer: A Neverending Story?

Van Schil PE.

J Thorac Oncol. 2017 Sep;12(9):1338-1340. doi: 10.1016/j.jtho.2017.07.001. No abstract available.

25.

Intensive care in thoracic oncology.

Meert AP, Grigoriu B, Licker M, Van Schil PE, Berghmans T.

Eur Respir J. 2017 May 11;49(5). pii: 1602189. doi: 10.1183/13993003.02189-2016. Print 2017 May. Review.

26.

Pathogenetic role of endothelial nitric oxide synthase uncoupling during lung ischaemia-reperfusion injury.

Gielis JF, Quirynen L, Briedé JJ, Roelant E, Cos P, Van Schil PEY.

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):256-263. doi: 10.1093/ejcts/ezx125.

PMID:
28481990
27.

Oxidative and nitrosative stress during pulmonary ischemia-reperfusion injury: from the lab to the OR.

Gielis JF, Beckers PAJ, Briedé JJ, Cos P, Van Schil PE.

Ann Transl Med. 2017 Mar;5(6):131. doi: 10.21037/atm.2017.03.32. Review.

28.

Lung ischemia reperfusion injury: the therapeutic role of dipeptidyl peptidase 4 inhibition.

Beckers PAJ, Gielis JF, Van Schil PE, Adriaensen D.

Ann Transl Med. 2017 Mar;5(6):129. doi: 10.21037/atm.2017.01.41. Review.

29.

Salvage surgery after high-dose radiotherapy.

Van Breussegem A, Hendriks JM, Lauwers P, Van Schil PE.

J Thorac Dis. 2017 Apr;9(Suppl 3):S193-S200. doi: 10.21037/jtd.2017.03.88. Review.

30.

Salvage Operation in Case of Oligometastatic Disease.

Duchateau N, Van Bouwel E, Van Schil PE.

Ann Thorac Surg. 2017 May;103(5):e409-e411. doi: 10.1016/j.athoracsur.2016.11.019.

PMID:
28431712
31.

Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer.

Van Schil PE, Yogeswaran K, Hendriks JM, Lauwers P, Faivre-Finn C.

Expert Rev Anticancer Ther. 2017 Jun;17(6):555-561. doi: 10.1080/14737140.2017.1319766. Epub 2017 Apr 21. Review.

PMID:
28403675
32.

Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period.

Domen A, De Laet C, Vanderbruggen W, Gielis J, Hendriks JM, Lauwers P, Janssens A, Hiddinga B, Van Meerbeeck JP, Van Schil PE.

Acta Chir Belg. 2017 Jun;117(3):157-163. doi: 10.1080/00015458.2016.1272253.

PMID:
28399779
33.

Non-small cell lung cancer: the new T1 categories.

Van Schil PE.

F1000Res. 2017 Feb 22;6:174. doi: 10.12688/f1000research.10600.1. eCollection 2017. Review.

34.

Invited Commentary on "ITMIG Classification of Mediastinal Compartments and Multidisciplinary Approach to Mediastinal Masses".

Van Schil PE, Heyman S.

Radiographics. 2017 Mar-Apr;37(2):436-438. doi: 10.1148/rg.2017160213. No abstract available.

PMID:
28287941
35.

Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017.

MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M, Rubin GD, Schaefer-Prokop CM, Travis WD, Van Schil PE, Bankier AA.

Radiology. 2017 Jul;284(1):228-243. doi: 10.1148/radiol.2017161659. Epub 2017 Feb 23.

PMID:
28240562
36.

Local Anesthesia for Percutaneous Thoracic Endovascular Aortic Repair.

van Dorp M, Gilbers M, Lauwers P, Van Schil PE, Hendriks JM.

Aorta (Stamford). 2016 Jun 1;4(3):78-82. doi: 10.12945/j.aorta.2016.16.002. eCollection 2016 Jun.

37.

Management of stage I and II nonsmall cell lung cancer.

McDonald F, De Waele M, Hendriks LE, Faivre-Finn C, Dingemans AC, Van Schil PE.

Eur Respir J. 2017 Jan 3;49(1). pii: 1600764. doi: 10.1183/13993003.00764-2016. Print 2017 Jan. Review.

38.

How to deal with subcentimeter lung cancer: a moving target!

Van Schil PE.

J Thorac Dis. 2016 Oct;8(10):E1221-E1225. No abstract available.

39.

Dysregulation of the renin-angiotensin system during lung ischemia-reperfusion injury.

Kehoe K, Gielis JF, Vliegen G, Van Elzen R, Verkerk R, Driessens E, Domen A, Lambeir AM, Maes L, Cos P, De Meester I, Van Schil PE.

Exp Lung Res. 2016 Aug;42(6):277-85. doi: 10.1080/01902148.2016.1207725. Epub 2016 Jul 20.

PMID:
27437782
40.

Solitary fibrous tumor of the pleura with associated Doege-Potter syndrome.

Reuvers JR, van Dorp M, Van Schil PE.

Acta Chir Belg. 2016 Dec;116(6):386-387. doi: 10.1080/00015458.2016.1171079. Epub 2016 Jul 4.

PMID:
27376978
41.

Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.

Sorber L, Zwaenepoel K, Deschoolmeester V, Van Schil PE, Van Meerbeeck J, Lardon F, Rolfo C, Pauwels P.

Lung Cancer. 2017 May;107:100-107. doi: 10.1016/j.lungcan.2016.04.026. Epub 2016 May 4. Review.

PMID:
27180141
42.

Linking CD11b (+) Dendritic Cells and Natural Killer T Cells to Plaque Inflammation in Atherosclerosis.

Rombouts M, Ammi R, Van Brussel I, Roth L, De Winter BY, Vercauteren SR, Hendriks JM, Lauwers P, Van Schil PE, De Meyer GR, Fransen E, Cools N, Schrijvers DM.

Mediators Inflamm. 2016;2016:6467375. doi: 10.1155/2016/6467375. Epub 2016 Mar 9.

43.

Scientific Advances in Lung Cancer 2015.

Tsao AS, Scagliotti GV, Bunn PA Jr, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan AU, McWilliams A, Tsao MS, Adusumilli PS, Rami-Porta R, Asamura H, Van Schil PE, Darling GE, Ramalingam SS, Gomez DR, Rosenzweig KE, Zimmermann S, Peters S, Ignatius Ou SH, Reungwetwattana T, Jänne PA, Mok TS, Wakelee HA, Pirker R, Mazières J, Brahmer JR, Zhou Y, Herbst RS, Papadimitrakopoulou VA, Redman MW, Wynes MW, Gandara DR, Kelly RJ, Hirsch FR, Pass HI.

J Thorac Oncol. 2016 May;11(5):613-638. doi: 10.1016/j.jtho.2016.03.012. Epub 2016 Mar 22. Review.

44.

Stage IIIA-N2 non-small-cell lung cancer: from 'surprise' involvement to surgical nightmare.

Van Schil PE.

Eur J Cardiothorac Surg. 2016 Jun;49(6):1613-4. doi: 10.1093/ejcts/ezv457. Epub 2015 Dec 30. No abstract available.

PMID:
26719400
45.

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group.

Dietel M, Bubendorf L, Dingemans AM, Dooms C, Elmberger G, García RC, Kerr KM, Lim E, López-Ríos F, Thunnissen E, Van Schil PE, von Laffert M.

Thorax. 2016 Feb;71(2):177-84. doi: 10.1136/thoraxjnl-2014-206677. Epub 2015 Nov 3. Review.

46.

eComment. Quality of life in thoracic surgery: often neglected but of vital importance!

Van Schil PE.

Interact Cardiovasc Thorac Surg. 2015 Oct;21(4):419. doi: 10.1093/icvts/ivv220. No abstract available.

PMID:
26392578
47.

Aortic Dissection Limited to Abdominal Aorta: an Underrecognized Entity?

Vermeersch N, Hendriks JM, Lauwers P, Salgado R, Van Schil PE.

Acta Chir Belg. 2015 Jul-Aug;115(4):293-8.

PMID:
26324032
48.

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Baas P, Fennell D, Kerr KM, Van Schil PE, Haas RL, Peters S; ESMO Guidelines Committee.

Ann Oncol. 2015 Sep;26 Suppl 5:v31-9. doi: 10.1093/annonc/mdv199. Epub 2015 Jul 28. No abstract available.

PMID:
26223247
49.

Treatment of pneumothorax: minimally or maximally invasive?

Van Schil PE.

Eur J Cardiothorac Surg. 2016 Mar;49(3):868-9. doi: 10.1093/ejcts/ezv237. Epub 2015 Jul 11. No abstract available.

PMID:
26164262
50.

Preclose Percutaneous Endurant™ Endografting with the Proglide™ Device: a Safe and Feasible Combination.

van Dorp M, Ruyssers M, Amajoud Z, Lauwers P, Van Schil PE, Hendriks JM.

Acta Chir Belg. 2015 May-Jun;115(3):219-23.

PMID:
26158254

Supplemental Content

Loading ...
Support Center